Search

everythinglearnresearchcommunity

for

Search:↓

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Genetic differences affect how people respond to COVID-19.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Skin symptoms like rashes and hives can help identify COVID-19 early.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Five FDA-approved drugs may help block COVID-19 virus entry.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Cepharanthine shows promise as a COVID-19 treatment.

Skin symptoms can be a sign of COVID-19 and may worsen with stress.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Five FDA-approved drugs may help block COVID-19 virus entry.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.